Featured
Lead report
美股
Lead report
Kardigan Soars on Nasdaq Debut: Market Enthusiasm Unabated After Upsized IPO, Digital Health Sector in Spotlight
Health tech company Kardigan surged 30% on its Nasdaq debut after an upsized and priced-up IPO, raising $324 million. The company focuses on AI-driven digital therapeutics and chronic disease management, with strong investor demand reflecting bullish sentiment in the healthcare sector.
美股
Healthcare Weekly: GSK, Parabilis Medicines, and Novo Nordisk in Focus
A deep dive into three key developments in the US healthcare sector this week: GSK's RSV vaccine progress, Parabilis Medicines' rare disease breakthrough, and Novo Nordisk's GLP-1 competition and capacity expansion, offering investment insights.
美股
Parabilis Medicines IPO Priced at $19 Per Share, Upsized Offering
Biotech firm Parabilis Medicines completes IPO at $19 per share, upsizing to 12 million shares and raising approximately $228 million, as market focuses on its precision medicine pipeline progress.
